Skip to main content
SpringerLink
Log in

Cardiovascular Disease in Racial/Ethnic Minorities: Overview and Perspectives

  • Chapter
Cardiovascular Disease in Racial and Ethnic Minorities

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 830 Accesses

Abstract

African-Americans have the highest rate of coronary disease mortality, premature death (including sudden death), stroke (fatal and non-fatal), hypertension, type 2 diabetes, and obesity (especially black females) when compared to whites. Cardiovascular health, life-expectancy, and health care, while improving dramatically for all Americans over the last century, have not been distributed equitably. Racial/ethnic-based CVD research may offer the opportunity to clarify vital environmental and inherited aspects in the development of CVD, illustrate the importance of lifestyle, unmask variations in clinical practice, and potentially improve health-care delivery for all Americans. A review of the various chapters of this book is included, specifically highlighting important concepts related to the prevention of cardiovascular conditions in racial/ethnic minorities through the consideration of risk factors, treatment options, and clinical trials.

To combat the distressingly high rates of hypertension morbidity and mortality in African Americans, the International Society on Hypertension in Blacks (ISHIB) promulgated guidelines suggesting combination therapy and more intensive therapy for most black patients. Similarly, the National Cholesterol Education Program Adult Treatment Panel III delineates special considerations in African Americans. Simply identifying racial/ethnic health disparities will not eliminate them. Health-care education in the future should recognize the essential nature of the patient’s cultural identity and experiences and understanding social factors and support systems. Clinicians must integrate an understanding of culture, lifestyle, socioeconomic status, the impact of psychological stress, and bias within the health-care system to assist patients with achieving positive outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. U.S. Census Bureau News. U.S. Department of Commerce. An Older and More Diverse Nation by Midcentury. [Internet] Washington, D.C. [Modified 2008 Aug 14; cited 2008 Sept 2] Accessed from: www.census.gov/Press-Release/www/releases/archives/population/012496.html

  2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117(4):e25–146.

    Article  PubMed  Google Scholar 

  3. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiologic Health (CDRH), Office of the Commissioner (OC). Clinical Medical Guidance for Industry: Collection of Race and Ethnicity Data in Clinical Trials. [Modified 2005 Oct 3; cited 2008 Sept 2] Accessed from: http://www.fda.gov/cder/Guidance/5656fnl.htm

  4. Addressing Racial and Ethnic Disparities in Health Care Fact Sheet. AHRQ Publication No. 00-PO41. [Internet] Agency for Healthcare Research and Quality, Rockville, MD. [Modified 2000 Feb; cited 2008 Sept 2] Accessed from: http://www.ahrq.gov/research/disparit.htm

  5. Anderson GM, Bronskill SE, Mustard CA, Culyer A, Alter DA, Manuel DG. Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities. J Clin Epidemiol 2005; 58(8):757–762.

    Article  PubMed  Google Scholar 

  6. Rhoades DA. Racial misclassification and disparities in cardiovascular disease among American Indians and Alaska Natives. Circulation 2005; 111(10):1250–1256.

    Article  PubMed  Google Scholar 

  7. Flack JM, Wiist WH. Epidemiology of hypertension and hypertensive target-organ damage in the United States. J Assoc Acad Minor Phys 1991; 2(4):143–150.

    CAS  PubMed  Google Scholar 

  8. Crawford DC, Akey DT, Nickerson DA. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 2005; 6:287–312.

    Article  CAS  PubMed  Google Scholar 

  9. McKeigue PM. Prospects for admixture mapping of complex traits. Am J Hum Genet 2005; 76(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  10. Abate NI, Mansour YH, Meryem T, et al. Overweight and sympathetic overactivity in Black Americans. Hypertension 2001; 38:379–383.

    CAS  PubMed  Google Scholar 

  11. Gidding SS, Liu K, Bild DE, et al. Prevalence and identification of abnormal lipoprotein levels in a biracial population aged 23 to 35 years (the CARDIA study). The Coronary Risk Development in Young Adults study. Am J Cardiol 1996; 78:304–308.

    Article  CAS  PubMed  Google Scholar 

  12. Watkins LO, Neaton JD, Kuller LH. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual care group of the Multiple Risk Factor Intervention Trial. Am J Cardiol 1986; 57:538–545.

    Article  CAS  PubMed  Google Scholar 

  13. Hutchinson RG, Watson RL, Davis CE, et al. Racial differences in risk factors for atherosclerosis. The ARIC study. Angiology 1997; 48:279–290.

    Article  CAS  PubMed  Google Scholar 

  14. Clark LT, Ferdinand KC, Flack JM, et al. Coronary heart disease in African Americans. Heart Dis 2001; 3:97–108.

    Article  CAS  PubMed  Google Scholar 

  15. Keil JE, Sutherland SE, Hames CG, et al. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies. Arch Intern Med 1995; 155(14):1521–1527.

    Article  CAS  PubMed  Google Scholar 

  16. Clark LT, Maki KC, Galant R, Maron DJ, Pearson TA, Davidson MH. Ethnic differences in achievement of cholesterol treatment goals: results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II. J Gen Intern Med 2006; 21(4):320–6.

    Article  PubMed  Google Scholar 

  17. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low density lipoprotein cholesterol goals. Arch Intern Med 2000; 28:459–67.

    Article  Google Scholar 

  18. Williams ML, Morris MT, Ahmad U, Yousseff M, Li W, Ertel N. Racial differences in compliance with NCEP II recommendations for secondary prevention at a veterans affairs medical center. Ethn Dis 2002; 12:S1-58–62.

    PubMed  Google Scholar 

  19. ALLHAT Officers and Coordinators of the ALLHAT Collaborative Research Group. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002; 288:2988–3007.

    Google Scholar 

  20. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998; 39(1): 228–232.

    CAS  PubMed  Google Scholar 

  21. Hall WD, Clark LT, Wenger NK, et al. The metabolic syndrome in African Americans: a review. Ethn Dis 2003; 13:414–428.

    PubMed  Google Scholar 

  22. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutritional Examination Survey. JAMA 2002; 287(3):356–359.

    Article  PubMed  Google Scholar 

  23. Rowland ML, Fulwood R. Coronary heart disease risk factor trends in blacks between the first and second National Health and Nutrition Examination Surveys, United States, 1971-1980. Am Heart J 1984; 108:771–779.

    Article  CAS  PubMed  Google Scholar 

  24. Cutter GR, Burke GL, Dyer AR, et al. Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials 1991; 12:1S–25S, 51S–77S.

    Article  Google Scholar 

  25. Ferdinand KC, Clark LT, Watson KE, et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. Am J Cardiol 2006; 97(2):229–35.

    Article  CAS  PubMed  Google Scholar 

  26. Davidson MH, Maki KC, Pearson TA, et al. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol 2005; 96(4):556–563.

    Article  PubMed  Google Scholar 

  27. Hassan MI, Aschner Y, Manning CH, et al. Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. Cytokine 2003; 21:10–16.

    Google Scholar 

  28. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the united states, 1999-2004. JAMA 2006; 295: 1549–1555.

    Article  CAS  PubMed  Google Scholar 

  29. Kumanyika S. Obesity treatment in minorities. In: Wadden TA, Stunkard AJ, eds. Handbook of obesity treatment. New York: The Guilford Press; 2002:416–446.

    Google Scholar 

  30. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham Coronary Heart Disease Prediction Scores: results of a multiple ethnic groups investigation. JAMA 2001; 286(2):180–187.

    Article  PubMed  Google Scholar 

  31. Fox ER, Taylor J, Taylor H, et al. Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) Study: clinical correlates and influences on systolic and diastolic dysfunction. Am Heart J 2007; 153(2):238–244.

    Article  PubMed  Google Scholar 

  32. Rovner A, de las Fuentes L, Waggoner AD, et al. Characterization of left ventricular diastolic function in hypertension by use of Doppler tissue imaging and color M-mode techniques. J Am Soc Echocardiogr 2006; 19(7):872–879.

    Article  PubMed  Google Scholar 

  33. Jacobson DR, Pastore RD, Yaghoubian R, et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997; 336(7):466–473.

    Article  CAS  PubMed  Google Scholar 

  34. Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J 2008; 29(1):89–95.

    Article  PubMed  Google Scholar 

  35. Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med 1995 Apr; 162(4):322–327.

    CAS  PubMed  Google Scholar 

  36. Dries DL, Exner DV, Gersh BJ, et al. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med 1999; 340:609–616.

    Article  CAS  PubMed  Google Scholar 

  37. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001; 344:1351–1357.

    Article  CAS  PubMed  Google Scholar 

  38. Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F, Willett D, Victor RG. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension 2005 Jul; 46(1):124–129.

    Article  CAS  PubMed  Google Scholar 

  39. Steinberg HO, Paradisi G, Cronin J Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000; 101(17):2040–2046.

    CAS  PubMed  Google Scholar 

  40. Koh KK, Kang MH, Jin DK, et al. Vascular effects of estrogen in type II diabetic postmenopausal women. J Am Coll Cardiol 2001; 38(5):1409–1415.

    Article  CAS  PubMed  Google Scholar 

  41. Shekelle PG, Rich MW, Morton SC, et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 2003; 41(9):1529–1538.

    Article  CAS  PubMed  Google Scholar 

  42. Taylor AL, Lindenfeld J, Ziesche S, et al. Outcomes by gender in the African-American Heart Failure Trial. J Am Coll Cardiol 2006; 48(11):2263–2267.

    Article  PubMed  Google Scholar 

  43. Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003; 163(5):525–541.

    Article  PubMed  Google Scholar 

  44. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106(25):3143–3421.

    Google Scholar 

  45. Alberti KG, Zimmet P, Shaw J The metabolic syndrome—a new worldwide definition. Lancet 2005; 366(9491):1059–1062

    Article  PubMed  Google Scholar 

  46. Cohen JJ. The consequences of premature abandonment of affirmative action in medical school admissions. JAMA 2003; 289(9):1143–1149.

    Article  PubMed  Google Scholar 

  47. Barzansky B, Etzel SI. Educational programs in U.S. medical schools, 2002-2003. JAMA 2003; 290(9):1190–1196.

    Article  CAS  PubMed  Google Scholar 

  48. U.S. Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Professions. [Internet] The Registered Nurse Population: Findings from the March 2004 National Sample Survey of Registered Nurses [Modified 2006 June; cited 2008 Sept 2]. Accessed from: http://bhpr.hrsa.gov/healthworkforce/rnsurvey04/3.htm

  49. Hayes, B. Increasing the representation of underrepresented minority groups in US colleges and schools of pharmacy. Am J Pharm Educ 2008; 72(1):14.

    PubMed  Google Scholar 

  50. Berlin EA, Fowkes WC. A teaching framework for cross-cultural health care: application in family practice. West J Med 1983; 139(6):934–938.

    CAS  PubMed  Google Scholar 

  51. Carrasquillo O, Orav EJ, Brennan TA, Burstin HR. Impact of language barriers on patient satisfaction in an emergency department. J Gen Intern Med 1999; 14(2):82–87.

    Article  CAS  PubMed  Google Scholar 

  52. Baker DW, Hayes R, Fortier JP. Interpreter use and satisfaction with interpersonal aspects of care for Spanish-speaking patients. Med Care 1998; 36(10):1461–1470.

    Article  CAS  PubMed  Google Scholar 

  53. Cole PM. Cultural competence now mainstream medicine. Responding to increasing diversity and changing demographics. Postgrad Med 2004; 116(6):51–53.

    Article  PubMed  Google Scholar 

  54. Henry J Kaiser Family Foundation, American College of Cardiology Foundation (ACCF). Racial/Ethnic Differences in Cardiac Care: The Weight of the Evidence [Internet] [modified 2002 Oct 8; cited 2008 Sept 2]. Available from: http://www.kff.org/whythedifference/6040fullreport.pdf

  55. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. Strategy for Addressing Health Disparities FY 2002 — 2006 [Internet] [cited 2008 Sept 2]. Available from: http://www.nhlbi.nih.gov/resources/docs/plandisp.htm

  56. Department of Health and Human Services, Centers for Disease Control and Prevention. Racial and Ethnic Approaches to Community Health (REACH). [Internet] Atlanta, GA. [Modified 2008 May 1; cited 2008 Sept 2]. Available from: http://www.cdc.gov/reach

  57. Ferdinand KC. Lessons learned from the Healthy Heart Community Prevention Project in reaching the African American population. J Health Care Poor Underserved 1997; 8:366–371.

    CAS  PubMed  Google Scholar 

  58. Murray CJL, Kulkarni SC, Michaud C, et al. Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med 2006; 3(9): e260.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Division, Emory University, 5355 Hunter Road, Atlanta, GA, 30349, USA

    K. C. Ferdinand MD

  2. Department of Internal Medicine, New Hanover Regional Medical Center, 212 Walnut Street, Wilmington, NC, 28401 #101, USA

    A. Armani MD

Authors
  1. K. C. Ferdinand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Armani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. C. Ferdinand MD .

Editor information

Editors and Affiliations

  1. Cardiology Division, Emory University, 5355 Hunter Road, Atlanta, GA, 30349, USA

    Keith C. Ferdinand MD

  2. Department of Internal Medicine, New Hanover Regional Medical Center, 212 Walnut Street, Wilmington, NC, 28401 #101, USA

    Annemarie Armani MD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ferdinand, K.C., Armani, A. (2009). Cardiovascular Disease in Racial/Ethnic Minorities: Overview and Perspectives. In: Ferdinand, K.C., Armani, A. (eds) Cardiovascular Disease in Racial and Ethnic Minorities. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-410-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-410-0_1

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-981-9

  • Online ISBN: 978-1-59745-410-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation